Symptoms are also often dose-dependent, meaning they may temporarily flare after a dose increase before settling back down
doi: 10.3389/fphar.2026.1754721 Received 26 November 2025 Revised 28 February 2026 Accepted 03 March 2026 Published 19 March 2026 Volume 17 - 2026 Edited by Achuthan Raghavamenon, Amala Cancer Research Centre, India Reviewed by Abdul Rahim Chethikkattuveli Salih, Terasaki Institute for Biomedical Innovation, United States Julio Plaza-Diaz, Childrens Hospital of Eastern Ontario (CHEO), Canada Updates Copyright 2026 Hu, Tian, Yang, Zhang, Zhang, Xu and Lu
Individuals with BED frequently experience comorbid conditions including obesity, type 2 diabetes, hypertension, and metabolic syndrome
At Atlanta Bariatrics, GLP-1 treatment is combined with expert medical supervision, in-office registered dietitian support, and a customized plan tailored to your unique health, lifestyle, and goals for long-term success